January 17, 2018 / 12:46 PM / 3 months ago

BRIEF-Neurometrix, Glaxosmithkline Announce Collaboration To Develop Quell Wearable Pain Relief Technology

Jan 17 (Reuters) - Glaxosmithkline Consumer Healthcare Ltd :

* NEUROMETRIX AND GLAXOSMITHKLINE CONSUMER HEALTHCARE ANNOUNCE STRATEGIC COLLABORATION TO DEVELOP AND EXPAND ACCESS TO QUELL WEARABLE PAIN RELIEF TECHNOLOGY

* NEUROMETRIX INC - GSK CONSUMER HEALTHCARE ACQUIRES EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S.

* NEUROMETRIX INC - NEUROMETRIX RETAINS EXCLUSIVE OWNERSHIP OF QUELL TECHNOLOGY IN U.S. MARKET.

* NEUROMETRIX - CO, GSK CONSUMER HEALTHCARE TO CO-FUND DEVELOPMENT OF QUELL TECHNOLOGY FOR 3 YEARS BEGINNING IN 2018 THROUGH 2020

* NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO $5 MILLION FOR ASSETS RELATING TO QUELL TECHNOLOGY FOR MARKETS OUTSIDE U.S

* NEUROMETRIX - GSK CONSUMER HEALTHCARE TO PAY CO UP TO $21.5M FOR QUELL UPON ACHIEVEMENT OF CERTAIN MILESTONES Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below